Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02230020 · ClinicalTrials.gov registry record
Efficacy of High Flow Therapy in COPD At Home
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT02230020: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02230020 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02230020 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Preliminary data show that in COPD patients, HFT substantially decreases ventilatory demand during sleep. The central hypothesis of this proposal is that lowering ventilatory demand using nasal high-flow therapy during sleep will elevate lung function, reduce dyspnea on exertion and improve quality of life. Thus, this proposal aims will determine the effects HFT over time on 1) lung function; 2) dyspnea on exertion; and 3) quality of life.
Interventions
- DEVICE Nasal High Flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-08-15 |
| Est. Completion | 2015-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02230020
The ClinicalTrials.gov registry entry for NCT02230020 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal High Flow is the first listed.
NCT02230020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02230020 about?
NCT02230020 is a clinical study titled "Efficacy of High Flow Therapy in COPD At Home". Preliminary data show that in COPD patients, HFT substantially decreases ventilatory demand during sleep. The central hypothesis of this proposal is that lowering ventilatory demand using nasal high-flow therapy during sleep will elevate lung function, reduce dyspnea on exertion and improve quality ...
What is the current status of trial NCT02230020?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2013-08-15. Estimated completion is 2015-12-13.
What interventions are being tested in trial NCT02230020?
The interventions under investigation include: Nasal High Flow (DEVICE).
Who is sponsoring clinical trial NCT02230020?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.